(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCo...evelopmentAuthority(OPDA)wererecentlyawarded$2mill...ionBoard(CERB)inaprivate/publicpartnershiptoconstr...nLincolnCounty,WA. ,, "Thisinvestmentwillsignif...over70greenjobstoLincolnCounty,"saidBlueMarbleEner...
(Date:11/24/2009)..., DUBLIN,November24/PRNewswire-FirstCall/--Shire...pharmaceuticalcompany,today,announcedthatithassubm...rasealfa,thecompany,senzymereplacementtherapyindev...isthethirdmarketing,applicationforvelaglucerasealf...eUnitedStatesandCanada. , Basedonaglobalsuppl...
(Date:11/24/2009)... Program Connects Customers w...les Collected with DNA Genotek Products , ...009 -- DNA Genotek , a leading provider of produc... and preparation, today announced its new global p...ancements for DNA Genotek,s partner community and ...
(Date:11/23/2009)...AMPAIGN, Ill. You can think of it as origami ver...ity of Illinois have developed a technique for fab...icon structures from thin films by coupling photol...pillary interactions. , The films, only a few mic...ot possible with thicker pieces of the same materi...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2.... 28 Beckman,Coulter, Inc. (NYSE: BEC ), announc...ents with Adventist Health to provide a broad rang...t approximately $36 million over,six years. Advent... care,system with facilities in California, Hawaii...scom.com/cgi-bin/prnh/20031202/BECLOGO ), Under t...
...um Drives 71% Year-Over-Year Growth in Core ... Calif., Oct. 28 Cepheid (Nasdaq:,CPHD) today rep....9,million, an increase of 24% over the third quar...$(0.11) per share, which compares to revenue of $3....09) per share, in the third,quarter of fiscal 200...
...ovavax, Inc.,(Nasdaq: NVAX ) a clinical-stage vac...vi, President and Chief Executive Officer, will be... am. (PT) on October 30, 2008 at the,Palace Hotel ...vide an,overview of the company,s strategy, resear...esentation can be accessed via the Company website...
Other Biology Technology:Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care 2Cepheid Reports Third Quarter Revenue of $44.9 Million 2Cepheid Reports Third Quarter Revenue of $44.9 Million 3Cepheid Reports Third Quarter Revenue of $44.9 Million 4Cepheid Reports Third Quarter Revenue of $44.9 Million 5Cepheid Reports Third Quarter Revenue of $44.9 Million 6Cepheid Reports Third Quarter Revenue of $44.9 Million 7Cepheid Reports Third Quarter Revenue of $44.9 Million 8Cepheid Reports Third Quarter Revenue of $44.9 Million 9Cepheid Reports Third Quarter Revenue of $44.9 Million 10Cepheid Reports Third Quarter Revenue of $44.9 Million 11Cepheid Reports Third Quarter Revenue of $44.9 Million 12Cepheid Reports Third Quarter Revenue of $44.9 Million 13...ist has discovered key appetite control cells in t...ased hunger and potentially weight-gain as we grow...oendocrinologist with Monash University,s Departme..., Dr Andrews found that appetite-suppressing cell...aid the degeneration is more significant following...
... many men during their fight against prostate canc...searchers have found. The findings were published ...edings of the National Academy of Sciences . , Th...edeviled patients for decades. Hormone therapy, a ...ncer, generally keeps the cancer at bay for a year...
...s(TM) Wireless Data Communications Link School ..., WALL, N.J., Aug. 20 BIO-key International,Inc....sed biometric,identification and wireless public s...of MobileSRO(TM) and MobileCampus(TM), silent, sec...-12 schools and higher,education, respectively., ...
Other Biology News:Killer carbs -- Monash scientist finds the key to overeating as we age 2Why a common treatment for prostate cancer ultimately fails 2Why a common treatment for prostate cancer ultimately fails 3Why a common treatment for prostate cancer ultimately fails 4BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 2BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 3Mouse Anti-Human CD182 (CXCR2) Monoclonal Antibody, Unconjugated, Clone 5E8/CXCR2 from BioLegend
Rabbit Anti-Human Purinergic Receptor P2Y12 Polyclonal Antibody, Unconjugated from IMGENEX
Goat Anti-Human AGAP1 / Centaurin, gamma 2 Polyclonal Antibody, Unconjugated from IMGENEX
Rabbit Anti-Human CLAN Polyclonal Antibody, Unconjugated from IMGENEX
Biology Products: